Torrent Pharmaceuticals Limited — Updates, 09-07-2026: Press Release
09-07-2026 | 05:34 pm
09-07-2026 | 05:34 pm
Torrent Pharma initiated a voluntary recall of select Semalix injection batches (2mg & 4mg) due to a manufacturer's technical evaluation. This operational move may incur minor costs; patient safety and other Semaglutide products remain unaffected.
No comments yet. Be the first to comment!
